Skip to main content

Incidence of pertussis in patients of general practitioners in Poland

  • P. STEFANOFF (a1), I. A. PARADOWSKA-STANKIEWICZ (a1), M. LIPKE (a1), E. KARASEK (a1), W. RASTAWICKI (a1), A. ZASADA (a1), S. SAMUELS (a2), H. CZAJKA (a3) and R. G. PEBODY (a4)...

We estimated the incidence of pertussis in patients consulting general practitioners (GPs). Between July 2009 and April 2011, we conducted a prospective cohort study of patients attending 78 general practices (158 863 persons overall). We included patients aged ⩾3 years, with cough lasting 2–15 weeks, who gave informed consent. GPs interviewed eligible patients, collected a blood specimen, and a nasopharyngeal swab. At follow-up 30–60 days after the initial visit, physicians collected a second blood specimen and conducted patient interview. Cases were confirmed by specific IgA and/or IgG antibody titre exceeding significantly the general population background level or detection of bacterial DNA by real-time PCR. During the study period, 3864 patients with prolonged cough consulted the participating GPs, of those 1852 met the inclusion criteria, 1232 were recruited, and 288 were confirmed as pertussis cases (4% by PCR, 96% by serology). The adjusted incidence rate was 201·1/100 000 person-years [95% confidence interval (CI) 133·9–302·0], ranging from 456·5 (95% CI 239·3–870·8) in the 15–19 years group to 94·0 (95% CI 33·4–264·5) in the 25–29 years group. The reporting ratio was 61, ranging from 4 in those aged 3–5 years, to 167 in those aged 65–69 years. The study confirmed high incidence of pertussis in all age groups in the general population, in particular in adults, not appropriately documented by the existing surveillance system.

Corresponding author
* Author for correspondence: Dr P. Stefanoff, Department of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Postboks 4404 Nydalen, 0403 Oslo, Norway. (Email:
Hide All
1. Hewlett, EL. Bordetella species. In: Mandell, GL, Bennett, JE, Dolin, R. Principles and Practice of Infectious Diseases, 6th edn. Philadelphia, PA: Churchill Livingstone, 2004, pp. 27012708.
2. Crowcroft, NS, Pebody, RG. Recent developments in pertussis. Lancet 2006; 367: 19261936.
3. Hewlett, EL, Edwards, KM. Clinical practice: pertussis – not just for kids. New England Journal of Medicine 2005; 352: 12151222.
4. Cherry, JD. Historical review of pertussis and the classical vaccine. Journal of Infectious Diseases 1996; 174: S259S263.
5. Wirsing von Konig, CH, et al. Pertussis of adults and infants. Lancet Infectious Diseases 2002; 2: 744750.
6. Tan, T, Trindade, E, Skowronski, D. Epidemiology of pertussis. Pediatric Infectious Diseases Journal 2005; 24 (5 Suppl.): S10S18.
7. Skowronski, DM, et al. The changing age and seasonal profile of pertussis in Canada. Journal of Infectious Diseases 2002; 185: 14481453.
8. Wirsing von König, CH, et al. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995; 346: 13261329.
9. National Institute of Public Health-National Institute of Hygiene. Annual reports ‘Vaccinations in Poland’ ( Accessed 23 January 2013.
10. Gzyl, A, et al. Pertussis in Poland. International Journal of Epidemiology 2004; 33: 358365.
11. World Health Organization. Recommended surveillance standard of pertussis ( Accessed 23 January 2013.
12. Rastawicki, W, et al. Reliability of the cut-off value in the routine serodiagnosis of pertussis performed by the commercial ELISA assays [in Polish]. Medycyna Dowiadczalna Mikrobiologia 2011; 63: 7380.
13. Kösters, K, Riffelmann, M, Wirsing von König, CH. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. Journal of Medical Microbiology 2001; 50: 436440.
14. Poland Central Statistical Office. Local databank ( Accessed 2 June 2013.
15. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011.
16. Lohr, S. Sampling: Design and Analysis , 2nd edn. Boston, MA: Brooks/Cole, Cengage Learning, 2009, pp. 344.
17. Winter, N. SURVWGT: Stata module to create and manipulate survey weights. Boston College Department of Economics, 2002, revised in September 2008 ( Accessed 23 January 2013.
18. Schmitt-Grohé, S, et al. Pertussis in German adults. Clinical Infectious Diseases 1995; 21: 860866.
19. Nennig, ME, et al. Prevalence and incidence of adult pertussis in an urban population. Journal of American Medical Association 1996; 275: 16721674.
20. Miller, E, et al. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Communicable Disease and Public Health 2000; 3: 132134.
21. Strebel, P, et al. Population-based incidence of pertussis in adolescents and adults, Minnesota, 1995–1996. Journal of Infectious Diseases 2001; 183: 13531359.
22. Gilberg, S, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. Journal of Infectious Diseases 2002; 186: 415418.
23. Lasserre, A, et al. Pertussis incidence in adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Eurosurveillance 2011; 16: pii = 19783.
24. Pebody, RG, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiology and Infection 2005; 133: 159171.
25. Kretzschmar, M, Teunis, PF, Pebody, RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Medicine 2010; 7: e1000291.
26. Mooi, FR, van der Maas, NA, De Melker, HE. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiology and Infection. Published online: 13 February 2013 . doi:10.1017/S0950268813000071.
27. André, P, et al. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. Journal of Clinical Microbiology 2008; 46: 16721677.
28. Guiso, N, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology and Infectious Diseases 2011; 30: 307312.
29. Riffelmann, M, et al. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis . Journal of Clinical Microbiology 2010; 48: 44594463.
30. He, Q, et al. High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis in European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Eurosurveillance 2012; 17: pii = 20 239.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Stefanoff Supplementary Material
Stefanoff Supplementary Material

 Word (26 KB)
26 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed